Methylation of MLH1 is also a major molecular determinant of CIMP-positive (CIMP+) CRC and is often included in the traditional CIMP markers panel; however, MLH1 methylation-associated features have not been investigated fully in CIMP+ CRC [11]. The gene discussed is MLH1; the disease is colorectal carcinoma.